BK
74
3
BMY
55
-8
SE
60
-3
M
31
-3
FMC
23
-3
PGR
59
-3
MTB
65
-2
LEN
50
-2
AA
56
15
STZ
52
-6
JNJ
41
3
HST
39
-3
LLY
28
-8
ETR
65
2
ROP
53
-9
K
51
-3
RSG
65
-3
DRI
50
-3
SJM
9
-5
MSFT
48
-9
BK
74
3
BMY
55
-8
SE
60
-3
M
31
-3
FMC
23
-3
PGR
59
-3
MTB
65
-2
LEN
50
-2
AA
56
15
STZ
52
-6
JNJ
41
3
HST
39
-3
LLY
28
-8
ETR
65
2
ROP
53
-9
K
51
-3
RSG
65
-3
DRI
50
-3
SJM
9
-5
MSFT
48
-9
Financhill
Back

RiverNorth Managed Duration MuniFd Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
58

RMM
RiverNorth Managed Duration MuniFd

Last Price:
15.55
Seasonality Move:
7.83%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
58
RiverNorth Managed Duration MuniFd (RMM) is a Buy

Is RiverNorth Managed Duration MuniFd a Buy, Sell or Hold?

  • The current RiverNorth Managed Duration MuniFd [RMM] share price is $15.52. The Score for RMM is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • RMM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RMM Stock Price Chart

What is RiverNorth Managed Duration MuniFd's stock price today?

  • The RiverNorth Managed Duration MuniFd share price today is $15.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMM is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RMM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 46.57 Sell
Chaikin Money Flow: -52652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.38 - 15.84) Sell
Bollinger Bands (100): (15.32 - 15.86) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RMM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.55 Sell
20-day SMA: 15.54 Sell
50-day SMA: 15.77 Sell
200-day SMA: 15.27 Buy
8-day EMA: 15.56 Sell
20-day EMA: 15.58 Sell
50-day EMA: 15.63 Sell
200-day EMA: 15.33 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

RiverNorth Managed Duration MuniFd Earnings Growth & RMM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

RiverNorth Managed Duration MuniFd Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):